Key result
Plasma levels of vitronectin were the most reliable predictor for ruling out paroxysmal atrial fibrillation, demonstrating a specificity of 88%, sensitivity of 83%, and an AUC of 0.96.
Why the study?
Because significant changes occur in major fibrinolytic indicators during the early hours of paroxysmal atrial fibrillation, the authors sought to evaluate these indicators as diagnostic tools to rule out PAF.
Do fibrinolytic indicators, particularly vitronectin, accurately rule out paroxysmal atrial fibrillation?
Case-Control (n=103)
No
Do fibrinolytic indicators, particularly vitronectin, accurately rule out paroxysmal atrial fibrillation?
Plasma vitronectin levels demonstrate high diagnostic accuracy for ruling out paroxysmal atrial fibrillation, significantly outperforming D-dimer.
Answers are grounded in this paper and cite their sources.
May support vitronectin as paroxysmal AF rule-out biomarker; leaves open prospective validation before clinical use.
Diagnostic tests are a cornerstone in modern medicine. They are used not only to confirm the presence of a disease but also to rule out the disease in healthy subjects. Tests with two outcome categories (i.e. presence/absence) are known as dichotomous tests. Their inherent validity is determined by sensitivity and specificity and the receiver operating characteristic (ROC) curve is known to be a simple, yet complete plot that displays the full picture of trade-off between the sensitivity (true positive rate) and (1- specificity) (false positive rate) across a series of cut-off points. Our study found that, even in the early hours of paroxysmal atrial fibrillation, there were significant changes in major indicators of fibrinolysis, namely plasminogen level, t-PA level, PAI-1 activity, α2-antiplasmin activity, vitronectin and D-dimer plasma levels. We believe that they are closely related and stem from the disease itself. This gave us reason, using these indicators as predictors, to search for a diagnostic option to rule out PAF. We used statistical models of logistic regression analysis and ROC to achieve this. Values of p<0.05 were considered statistically significant. Plasma levels of vitronectin have been found to be the most reliable predictor for ruling out PAF (specificity 88%, sensitivity 83%, AUC 0.96), while D-dimer levels had the lowest diagnostic values (37% specificity, 81% sensitivity, AUC 0.56). The obtained results are not only of pure scientific but also of applied nature. They could be used to improve identification of patients at risk for PAF embolism, and assist in the choice of thromboprophylaxis.
No takes yet. Share an insight, caveat, or question.
Prodanova et al. (2020) conducted a case-control in Paroxysmal Atrial Fibrillation (n=103). Fibrinolytic markers (Vitronectin) vs. Controls in sinus rhythm was evaluated on Absence of PAF manifestation predicted by vitronectin plasma levels (OR 76.444, p=<0.001). Plasma levels of vitronectin were the most reliable predictor for ruling out paroxysmal atrial fibrillation, demonstrating a specificity of 88%, sensitivity of 83%, and an AUC of 0.96.
Synapse has enriched 10 related papers. Consider them for comparative context: